Apple has reportedly bought NextVR, a US-based virtual reality broadcasting technology developer backed by a host of corporate venturing units, for about $100m.

The Pharamron-backed oncology drug developer floated at the top of its range while increasing the number of shares in the offering.

Lilly Asia Ventures and Johnson & Johnson Innovation – JJDC are both investing in a series A round for the cell therapy developer, a spinoff from Genscript Biotech.